Dengue

[1]  A. Barrett,et al.  Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. , 2019, The Lancet. Infectious diseases.

[2]  S. Ritchie.  Wolbachia and the near cessation of dengue outbreaks in Northern Australia despite continued dengue importations via travellers. , 2018, Journal of travel medicine.

[3]  R. T. Sasmono,et al.  Dengue infection in international travellers visiting Bali, Indonesia , 2018, Journal of travel medicine.

[4]  Nguyen Tien Huy,et al.  Definitions for warning signs and signs of severe dengue according to the WHO 2009 classification: Systematic review of literature , 2018, Reviews in medical virology.

[5]  A. Wilder-Smith,et al.  Dengue vaccine: reliably determining previous exposure. , 2018, The Lancet. Global health.

[6]  T. Westling,et al.  Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy , 2018, The New England journal of medicine.

[7]  Eva Harris,et al.  Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines. , 2018, Vaccine.

[8]  N. Zitzmann,et al.  Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus , 2018, Advances in experimental medicine and biology.

[9]  G. Ippolito,et al.  Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, January 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  D. Cummings,et al.  Reconstruction of antibody dynamics and infection histories to evaluate dengue risk , 2018, Nature.

[11]  Mathieu Nacher,et al.  Estimating the Risk of Vertical Transmission of Dengue: A Prospective Study. , 2018, The American journal of tropical medicine and hygiene.

[12]  Eduardo Massad,et al.  Estimating the probability of dengue virus introduction and secondary autochthonous cases in Europe , 2018, Scientific Reports.

[13]  Qiang Chen,et al.  Development of Antibody Therapeutics against Flaviviruses , 2017, International journal of molecular sciences.

[14]  M. Halloran,et al.  Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.

[15]  E. Harris,et al.  Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components , 2017, PLoS pathogens.

[16]  Peggy Geluykens,et al.  Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library , 2017, Antiviral research.

[17]  S. D. Fernando,et al.  Prophylactic and therapeutic interventions for bleeding in dengue: a systematic review , 2017, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  G. Coelho,et al.  Symptomatic dengue infection during pregnancy and livebirth outcomes in Brazil, 2007-13: a retrospective observational cohort study. , 2017, The Lancet. Infectious diseases.

[19]  Laura C Rodrigues,et al.  Symptomatic dengue infection during pregnancy and the risk of stillbirth in Brazil, 2006-12: a matched case-control study. , 2017, The Lancet. Infectious diseases.

[20]  D. Gubler,et al.  Chymase Level Is a Predictive Biomarker of Dengue Hemorrhagic Fever in Pediatric and Adult Patients , 2017, The Journal of infectious diseases.

[21]  G. Ippolito,et al.  Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  D. Missé,et al.  Dengue subgenomic flaviviral RNA disrupts immunity in mosquito salivary glands to increase virus transmission , 2017, PLoS pathogens.

[23]  D. Glaesser,et al.  Global travel patterns: an overview. , 2017, Journal of travel medicine.

[24]  Z. Babiker,et al.  Imported dengue fever in East London: a 6-year retrospective observational study , 2017, Journal of travel medicine.

[25]  J. Low,et al.  Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial , 2017, The Lancet.

[26]  Alan D. Lopez,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.

[27]  N. M. Dung,et al.  The value of daily platelet counts for predicting dengue shock syndrome: Results from a prospective observational study of 2301 Vietnamese children with dengue , 2017, PLoS neglected tropical diseases.

[28]  Scott C Weaver,et al.  Epidemic arboviral diseases: priorities for research and public health. , 2017, The Lancet. Infectious diseases.

[29]  J. Low,et al.  Current Status of Dengue Therapeutics Research and Development , 2017, The Journal of infectious diseases.

[30]  M. Guzmán,et al.  OSBPL10, RXRA and lipid metabolism confer African-ancestry protection against dengue haemorrhagic fever in admixed Cubans , 2017, PLoS pathogens.

[31]  J. Taubenberger,et al.  IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity , 2017, Science.

[32]  E. Ooi,et al.  Dengue virus compartmentalization during antibody-enhanced infection , 2017, Scientific Reports.

[33]  T. Yeo,et al.  Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study , 2017, Scientific Reports.

[34]  V. Louis,et al.  Mitigating Diseases Transmitted by Aedes Mosquitoes: A Cluster-Randomised Trial of Permethrin-Impregnated School Uniforms , 2017, PLoS neglected tropical diseases.

[35]  W. Ko,et al.  A Cohort Study of Adult Patients with Severe Dengue in Taiwanese Intensive Care Units: The Elderly and APTT Prolongation Matter for Prognosis , 2017, PLoS neglected tropical diseases.

[36]  C. Simmons,et al.  An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  Corry Quando Yahya,et al.  Management of severe dengue hemorrhagic fever and bleeding complications in a primigravida patient: a case report , 2016, Journal of Medical Case Reports.

[38]  A. Wilder-Smith,et al.  Markers of dengue severity: a systematic review of cytokines and chemokines. , 2016, Journal of General Virology.

[39]  J. Farrar,et al.  Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine. , 2016, The Journal of infectious diseases.

[40]  S. Mallal,et al.  Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity , 2016, Journal of Virology.

[41]  P. Tangkijvanich,et al.  Incidence and Clinical Outcome of Acute Liver Failure Caused by Dengue in a Hospital for Tropical Diseases, Thailand. , 2016, The American journal of tropical medicine and hygiene.

[42]  M. Diamond,et al.  Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin–Mediated Neutralization , 2016, The Journal of Immunology.

[43]  Mario Recker,et al.  The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study , 2016, PLoS medicine.

[44]  O. O'Connor,et al.  Vertical Transmission of Dengue Virus in the Peripartum Period and Viral Kinetics in Newborns and Breast Milk: New Data , 2016, Journal of the Pediatric Infectious Diseases Society.

[45]  J. Low,et al.  Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity , 2016, Nature Microbiology.

[46]  H. Margolis,et al.  Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians. , 2016, Journal of travel medicine.

[47]  Uma S. Kamaraj,et al.  Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients , 2016, PLoS neglected tropical diseases.

[48]  V. Balbino,et al.  Association of genetic polymorphisms of IL1β -511 C>T, IL1RN VNTR 86 bp, IL6 -174 G>C, IL10 -819 C>T and TNFα -308 G>A, involved in symptomatic patients with dengue in Brazil , 2016, Inflammation Research.

[49]  S. Rabenhorst,et al.  Association of Polymorphisms in IL1β -511C>T, IL1RN 86 bp VNTR, and IL6 -174G>C Genes with Clinical Dengue Signs and Symptoms in Brazilian Dengue Patients. , 2016, Viral immunology.

[50]  E. Harris,et al.  Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability , 2016, PLoS pathogens.

[51]  B. Custer,et al.  Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic. , 2016, The Journal of infectious diseases.

[52]  Isaac I. Bogoch,et al.  Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread of Zika Virus in Europe , 2016, EBioMedicine.

[53]  P. Young,et al.  The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design. , 2016, Antiviral research.

[54]  Uma S. Kamaraj,et al.  Molecular determinants of plaque size as an indicator of dengue virus attenuation , 2016, Scientific Reports.

[55]  Penghua Wang,et al.  Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes , 2016, Nature Microbiology.

[56]  A. Ganesan,et al.  A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria. , 2016, Journal of travel medicine.

[57]  David L. Smith,et al.  Quantifying the Epidemiological Impact of Vector Control on Dengue , 2016, PLoS neglected tropical diseases.

[58]  C. Hor,et al.  A Two-Year Review on Epidemiology and Clinical Characteristics of Dengue Deaths in Malaysia, 2013-2014 , 2016, PLoS neglected tropical diseases.

[59]  S. Whitehead.  Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine? , 2016, Expert review of vaccines.

[60]  M. R. Capeding,et al.  Symptomatic Dengue in Children in 10 Asian and Latin American Countries. , 2016, The New England journal of medicine.

[61]  B. Custer,et al.  Transfusion-Transmitted Dengue and Associated Clinical Symptoms During the 2012 Epidemic in Brazil. , 2016, The Journal of infectious diseases.

[62]  R. Ferguson,et al.  Dengue in Peace Corps Volunteers, 2000-14. , 2016, Journal of travel medicine.

[63]  L. Bowman,et al.  Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis , 2016, PLoS neglected tropical diseases.

[64]  T. Jaenisch,et al.  Vascular leakage in dengue – clinical spectrum and influence of parenteral fluid therapy , 2016, Tropical medicine & international health : TM & IH.

[65]  Eli Schwartz,et al.  Dengue fever among Israeli expatriates in Delhi, 2015: implications for dengue incidence in Delhi, India. , 2016, Journal of travel medicine.

[66]  D. Stinchcomb,et al.  A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone , 2016, Expert review of vaccines.

[67]  V. Louis,et al.  Characteristics of and factors associated with dengue vector breeding sites in the City of Colombo, Sri Lanka , 2016, Pathogens and global health.

[68]  E. Harris,et al.  Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes , 2016, PLoS neglected tropical diseases.

[69]  Eduardo Massad,et al.  Modeling Importations and Exportations of Infectious Diseases via Travelers , 2016, Bulletin of Mathematical Biology.

[70]  Cameron P. Simmons,et al.  Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[71]  D. Gubler,et al.  Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness , 2015, Science.

[72]  Nicholas Jackson,et al.  Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. , 2015, The New England journal of medicine.

[73]  Eva Harris,et al.  Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination , 2015, Science Translational Medicine.

[74]  D. Hume,et al.  Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity , 2015, Science Translational Medicine.

[75]  J. Rocklöv,et al.  Increasing Dengue Incidence in Singapore over the Past 40 Years: Population Growth, Climate and Mobility , 2015, PloS one.

[76]  Angel Balmaseda,et al.  Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial , 2015, BMJ : British Medical Journal.

[77]  David L. Smith,et al.  The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus , 2015, eLife.

[78]  Joacim Rocklöv,et al.  Estimating air travel-associated importations of dengue virus into Italy. , 2015, Journal of travel medicine.

[79]  O. Horstick,et al.  Reviewing Dengue: Still a Neglected Tropical Disease? , 2015, PLoS neglected tropical diseases.

[80]  S. Yacoub,et al.  A pregnant woman with acute cardiorespiratory failure: dengue myocarditis , 2015, The Lancet.

[81]  H. Wertheim,et al.  Microvascular and endothelial function for risk prediction in dengue: an observational study , 2015, The Lancet.

[82]  G. Carrasquilla,et al.  Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.

[83]  D. Gubler,et al.  Review article: Research on dengue during World War II revisited. , 2014, The American journal of tropical medicine and hygiene.

[84]  Bjoern Peters,et al.  The Human CD8+ T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes , 2014, Journal of Virology.

[85]  P. Pitisuttithum,et al.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial , 2014, The Lancet.

[86]  H. Margolis,et al.  Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody , 2014, PLoS Neglected Tropical Diseases.

[87]  S. Yacoub,et al.  Predicting outcome from dengue , 2014, BMC Medicine.

[88]  J. Connolly,et al.  Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. , 2014, The Lancet. Infectious diseases.

[89]  Fan Zhang,et al.  Corticosteroids for dengue infection. , 2014, The Cochrane database of systematic reviews.

[90]  A. Wilder-Smith,et al.  Severe neutropenia in dengue patients: prevalence and significance. , 2014, The American journal of tropical medicine and hygiene.

[91]  H. Wertheim,et al.  Cardiovascular manifestations of the emerging dengue pandemic , 2014, Nature Reviews Cardiology.

[92]  N. Tsuchiya,et al.  A replication study confirms the association of GWAS-identified SNPs at MICB and PLCE1 in Thai patients with dengue shock syndrome , 2014, BMC Medical Genetics.

[93]  Y. Leo,et al.  Challenges in Dengue Fever in the Elderly: Atypical Presentation and Risk of Severe Dengue and Hospita-Acquired Infection , 2014, PLoS neglected tropical diseases.

[94]  B. Yan,et al.  First Experimental In Vivo Model of Enhanced Dengue Disease Severity through Maternally Acquired Heterotypic Dengue Antibodies , 2014, PLoS pathogens.

[95]  A. Sette,et al.  T-Cell Immunity to Infection with Dengue Virus in Humans , 2014, Front. Immunol..

[96]  L. Alphey,et al.  Five Things to Know about Genetically Modified (GM) Insects for Vector Control , 2014, PLoS pathogens.

[97]  K Khan,et al.  The 2012 dengue outbreak in Madeira: exploring the origins. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[98]  Derek A T Cummings,et al.  A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. , 2014, The Journal of infectious diseases.

[99]  J. Connolly,et al.  Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue , 2014, Proceedings of the National Academy of Sciences.

[100]  G. Wang,et al.  Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir , 2013, Journal of Virology.

[101]  B. Alisjahbana,et al.  The Diagnostic and Prognostic Value of Dengue Non-Structural 1 Antigen Detection in a Hyper-Endemic Region in Indonesia , 2013, PloS one.

[102]  N. M. Dung,et al.  Clinical Characteristics of Dengue Shock Syndrome in Vietnamese Children: A 10-Year Prospective Study in a Single Hospital , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[103]  Eric Martinez,et al.  Dogma in Classifying Dengue Disease , 2013, The American journal of tropical medicine and hygiene.

[104]  E. Harris,et al.  Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year , 2013, PLoS neglected tropical diseases.

[105]  K. Boonnak,et al.  Human FcγRII Cytoplasmic Domains Differentially Influence Antibody-Mediated Dengue Virus Infection , 2013, The Journal of Immunology.

[106]  Edward C. Holmes,et al.  Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes , 2013, Proceedings of the National Academy of Sciences.

[107]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[108]  S. Halstead,et al.  Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection , 2013, Archives of Virology.

[109]  S. Halstead.  Dengue: The Syndromic Basis to Pathogenesis Research. Inutility of the 2009 WHO Case Definition , 2013, The American journal of tropical medicine and hygiene.

[110]  Saravudh Suvannadabba,et al.  Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial , 2012, The Lancet.

[111]  S. Sanjay,et al.  Ophthalmic Complications of Dengue Fever: a Systematic Review , 2012, Ophthalmology and Therapy.

[112]  A. Tatem,et al.  Web-based GIS: the vector-borne disease airline importation risk (VBD-AIR) tool , 2012, International Journal of Health Geographics.

[113]  C. T. Tam,et al.  Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[114]  Niranjan Nagarajan,et al.  A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients , 2012, The Journal of infectious diseases.

[115]  Cameron P. Simmons,et al.  Current concepts: Dengue , 2012 .

[116]  T. Sell,et al.  Lessons Learned during Dengue Outbreaks in the United States, 2001–2011 , 2012, Emerging infectious diseases.

[117]  D. N. Oliveira,et al.  Central nervous system involvement in dengue , 2012, Neurology.

[118]  N. Lennon,et al.  Dynamics of Dengue Disease Severity Determined by the Interplay Between Viral Genetics and Serotype-Specific Immunity , 2011, Science Translational Medicine.

[119]  Y. Teo,et al.  Genome-wide association study identifies susceptibility loci for Dengue shock syndrome at MICB and PLCE1 , 2011, Nature Genetics.

[120]  A. Barrett,et al.  Next generation dengue vaccines: a review of candidates in preclinical development. , 2011, Vaccine.

[121]  S. Kalayanarooj,et al.  Dengue--how best to classify it. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[122]  Cameron P. Simmons,et al.  Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue , 2011, PLoS neglected tropical diseases.

[123]  S. Ritchie,et al.  Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission , 2011, Nature.

[124]  S. Ritchie,et al.  The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations , 2011, Nature.

[125]  T. Hien,et al.  Multicentre prospective study on dengue classification in four South‐east Asian and three Latin American countries , 2011, Tropical medicine & international health : TM & IH.

[126]  A. Rothman.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms , 2011, Nature Reviews Immunology.

[127]  Subhash G. Vasudevan,et al.  Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection , 2011, Proceedings of the National Academy of Sciences.

[128]  V. Deubel,et al.  Clinical and Virological Factors Influencing the Performance of a NS1 Antigen-Capture Assay and Potential Use as a Marker of Dengue Disease Severity , 2011, PLoS neglected tropical diseases.

[129]  M. Diamond,et al.  Binding of Flavivirus Nonstructural Protein NS1 to C4b Binding Protein Modulates Complement Activation , 2011, The Journal of Immunology.

[130]  S. Halstead,et al.  Virus role during intraepidemic increase in dengue disease severity. , 2011, Vector borne and zoonotic diseases.

[131]  S. Sekaran,et al.  The Diagnostic Sensitivity of Dengue Rapid Test Assays Is Significantly Enhanced by Using a Combined Antigen and Antibody Testing Approach , 2011, PLoS neglected tropical diseases.

[132]  J. Cavanaugh,et al.  Upward Trend in Dengue Incidence among Hospitalized Patients, United States , 2011, Emerging infectious diseases.

[133]  T. van Gool,et al.  Travel-related Dengue Virus Infection, the Netherlands, 2006–2007 , 2011, Emerging infectious diseases.

[134]  A. James,et al.  Genetic elimination of dengue vector mosquitoes , 2011, Proceedings of the National Academy of Sciences.

[135]  H. Margolis,et al.  Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment , 2011, The American journal of tropical medicine and hygiene.

[136]  I. Radić,et al.  Autochthonous dengue fever in Croatia, August-September 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[137]  Sarah Murrell,et al.  Review of dengue virus and the development of a vaccine. , 2011, Biotechnology advances.

[138]  J. Farrar,et al.  Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status , 2011, The Journal of infectious diseases.

[139]  Y. Leo,et al.  Evaluation of the NS1 Rapid Test and the WHO Dengue Classification Schemes for Use as Bedside Diagnosis of Acute Dengue Fever in Adults , 2011, The American journal of tropical medicine and hygiene.

[140]  J. Farrar,et al.  Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam , 2011, The American journal of tropical medicine and hygiene.

[141]  Rosanna W. Peeling,et al.  Evaluation of diagnostic tests: dengue , 2010, Nature Reviews Microbiology.

[142]  Rosanna W. Peeling,et al.  Dengue: a continuing global threat , 2010, Nature Reviews Microbiology.

[143]  Alan L Rothman,et al.  Classification of dengue illness based on readily available laboratory data. , 2010, The American journal of tropical medicine and hygiene.

[144]  T. Hien,et al.  Liver Involvement Associated with Dengue Infection in Adults in Vietnam , 2010, The American journal of tropical medicine and hygiene.

[145]  D. Gubler,et al.  Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago. , 2010, Virology.

[146]  P. Desprès,et al.  First two autochthonous dengue virus infections in metropolitan France, September 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[147]  B. Guy,et al.  Development of sanofi pasteur tetravalent dengue vaccine , 2010, Human vaccines.

[148]  Soila Sukupolvi-Petty,et al.  Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3 , 2010, Journal of Virology.

[149]  J. Farrar,et al.  A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults , 2010, PLoS neglected tropical diseases.

[150]  M. Guzmán,et al.  Multi-Country Evaluation of the Sensitivity and Specificity of Two Commercially-Available NS1 ELISA Assays for Dengue Diagnosis , 2010, PLoS neglected tropical diseases.

[151]  J. Levick,et al.  Microvascular fluid exchange and the revised Starling principle. , 2010, Cardiovascular research.

[152]  N. Lennon,et al.  Emergence of the Asian 1 Genotype of Dengue Virus Serotype 2 in Viet Nam: In Vivo Fitness Advantage and Lineage Replacement in South-East Asia , 2010, PLoS neglected tropical diseases.

[153]  M. Guzmán,et al.  Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphism. , 2010, The American journal of tropical medicine and hygiene.

[154]  T. Scott,et al.  Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus Transmission , 2010, PLoS neglected tropical diseases.

[155]  Pauline Aw,et al.  Dengue Virus Surveillance for Early Warning, Singapore , 2010, Emerging infectious diseases.

[156]  D. Gubler,et al.  Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development , 2010, Current infectious disease reports.

[157]  Ralph S. Baric,et al.  Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses , 2010, PLoS pathogens.

[158]  Tyler R. Prestwood,et al.  Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. , 2010, Cell host & microbe.

[159]  Mark J. Schreiber,et al.  Frontiers in Dengue Virus Research , 2010 .

[160]  Peter A. Ryan,et al.  A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium , 2009, Cell.

[161]  Cameron P Simmons,et al.  Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. , 2009, The Journal of infectious diseases.

[162]  J. Farrar,et al.  Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. , 2009, The American journal of tropical medicine and hygiene.

[163]  R. Jarman,et al.  A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model , 2009, PLoS medicine.

[164]  R. Césaire,et al.  Prospective observational study of low thresholds for platelet transfusion in adult dengue patients , 2009, Transfusion.

[165]  D. Vaughn,et al.  TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. , 2009, The Journal of infectious diseases.

[166]  V. Lee,et al.  Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[167]  Edward C. Holmes,et al.  Dengue Virus Serotype 2 from a Sylvatic Lineage Isolated from a Patient with Dengue Hemorrhagic Fever , 2009, PLoS neglected tropical diseases.

[168]  Rosanna W. Peeling,et al.  Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests , 2009, Emerging infectious diseases.

[169]  W. Messer,et al.  Severe Dengue Epidemics in Sri Lanka, 2003–2006 , 2009, Emerging infectious diseases.

[170]  Eduardo Massad,et al.  Threat of Dengue to Blood Safety in Dengue-Endemic Countries , 2009, Emerging infectious diseases.

[171]  Eli Schwartz,et al.  Seasonality, Annual Trends, and Characteristics of Dengue among Ill Returned Travelers, 1997–2006 , 2008, Emerging infectious diseases.

[172]  M. Diamond,et al.  Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E , 2007, PLoS pathogens.

[173]  Puay Hoon Tan,et al.  The pathology of dengue hemorrhagic fever. , 2007, Seminars in diagnostic pathology.

[174]  J. Farrar,et al.  Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. , 2007, The Journal of infectious diseases.

[175]  Phyllis Kanki,et al.  HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. , 2007, Human immunology.

[176]  A. Nisalak,et al.  Natural History of Plasma Leakage in Dengue Hemorrhagic Fever: A Serial Ultrasonographic Study , 2007, The Pediatric infectious disease journal.

[177]  Jacqueline L Deen,et al.  The WHO dengue classification and case definitions: time for a reassessment , 2006, The Lancet.

[178]  J. Rigau-Pérez,et al.  Severe dengue: the need for new case definitions. , 2006, The Lancet. Infectious diseases.

[179]  E. Holmes,et al.  Molecular evolution of dengue 2 virus in Puerto Rico: positive selection in the viral envelope accompanies clade reintroduction. , 2006, The Journal of general virology.

[180]  Nicholas J White,et al.  Comparison of three fluid solutions for resuscitation in dengue shock syndrome. , 2005, The New England journal of medicine.

[181]  A. Failloux,et al.  Phylogeography of Aedes (Stegomyia) aegypti (L.) and Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae) based on mitochondrial DNA variations. , 2005, Genetical research.

[182]  S. Halstead,et al.  Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. , 2005, The American journal of tropical medicine and hygiene.

[183]  Sasithon Pukrittayakamee,et al.  Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand , 2004, Tropical medicine & international health : TM & IH.

[184]  N. M. Dung,et al.  Size and charge characteristics of the protein leak in dengue shock syndrome. , 2004, The Journal of infectious diseases.

[185]  K. Wong,et al.  Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. , 2004, The Journal of infectious diseases.

[186]  Tom Solomon,et al.  Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? , 2004, The American journal of tropical medicine and hygiene.

[187]  D. Gubler,et al.  Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus , 2003, Emerging infectious diseases.

[188]  Edward C Holmes,et al.  The origin, emergence and evolutionary genetics of dengue virus. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[189]  A. Nisalak,et al.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.

[190]  N. M. Dung,et al.  Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[191]  Christopher H Woelk,et al.  Phylogenetic evidence for adaptive evolution of dengue viruses in nature. , 2002, The Journal of general virology.

[192]  N. White,et al.  Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. , 2002, The American journal of tropical medicine and hygiene.

[193]  A. Nisalak,et al.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.

[194]  J. Simpson,et al.  Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. , 2001, The American journal of tropical medicine and hygiene.

[195]  P. Reiter,et al.  Aedes albopictus and the world trade in used tires, 1988-1995: the shape of things to come? , 1998, Journal of the American Mosquito Control Association.

[196]  J. Esko,et al.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.

[197]  R. Rico-Hesse,et al.  Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. , 1997, Virology.

[198]  P. Young,et al.  Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. , 1996, Virology.

[199]  S. Sinkins,et al.  Wolbachia superinfections and the expression of cytoplasmic incompatibility , 1995, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[200]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever. , 2014 .

[201]  S. Halstead,et al.  Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.

[202]  A. Nisalak,et al.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.

[203]  S. Halstead,et al.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.

[204]  SB Halstead,et al.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody , 1977, The Journal of experimental medicine.

[205]  S. Halstead,et al.  Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. , 1973, The Journal of infectious diseases.

[206]  S. Cohen,et al.  Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. , 1970, The Yale journal of biology and medicine.

[207]  Y. Teo,et al.  Genome-wide association study identifies susceptibility loci for Dengue shock syndrome at MICB and PLCE 1 , 2018 .

[208]  A. Wilder-Smith.  Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers. , 2018, Journal of travel medicine.

[209]  Chui Rhong. Chang,et al.  Zika in travellers 1947-2017: a systematic review. , 2018, Journal of travel medicine.

[210]  A. Wilder-Smith,et al.  Dengue virus not detected in human semen. , 2018, Journal of travel medicine.

[211]  P. Vidalain,et al.  A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host Factors. , 2018, Cell reports.

[212]  Dengue vaccine: WHO position paper, September 2018 - Recommendations. , 2018, Vaccine.

[213]  D. Poddighe,et al.  Paediatric Dengue Fever diagnosed through parents' epidemiologic report and preventive strategy during the acute phase of infection. , 2016, Journal of travel medicine.

[214]  K. Khan,et al.  Exploring the origin and potential for spread of the 2013 dengue outbreak in Luanda, Angola. , 2013, Global health action.

[215]  M. Guzmán,et al.  Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[216]  A. Durbin,et al.  Dengue vaccine candidates in development. , 2010, Current topics in microbiology and immunology.

[217]  V. Paz-Soldan,et al.  Maternal dengue and pregnancy outcomes: a systematic review. , 2010, Obstetrical & gynecological survey.

[218]  M. Gonçalo,et al.  Dengue Hemorrhagic Fever Transmitted by Blood Transfusion , 2008 .

[219]  E. Lim,et al.  Post-infectious fatigue syndrome in dengue infection. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[220]  S I Hay,et al.  The global distribution of yellow fever and dengue. , 2006, Advances in parasitology.

[221]  S. Halstead,et al.  Neutralization and antibody-dependent enhancement of dengue viruses. , 2003, Advances in virus research.

[222]  A. Rothman.  Immunology and immunopathogenesis of dengue disease. , 2003, Advances in virus research.

[223]  J. Roehrig.  Antigenic structure of flavivirus proteins. , 2003, Advances in virus research.

[224]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[225]  P. Alderson,et al.  Colloids versus crystalloids for fluid resuscitation in critically ill patients. , 2000, The Cochrane database of systematic reviews.

[226]  F. Curry,et al.  Microvascular permeability. , 1999, Physiological reviews.

[227]  Shane Marley,et al.  Control of Communicable Diseases Manual , 1997, Annals of Internal Medicine.

[228]  M. Saeed,et al.  Dengue and Dengue Hemorrhagic Fever , 2015 .

[229]  M. Guzmán,et al.  Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. , 1989, Bulletin of the World Health Organization.

[230]  A. Nisalak,et al.  A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.